Speaker illustration

Miss Sandra Morana Fernandez

Health Research Institute of Santiago de Compostela, Santiago de Compostela (Spain)

Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats.

Event: ESC Congress 2022

Topic: Metabolism

Session: Metabolism, mitochondria, and heart diseases

Thumbnail

This platform is supported by

logo Novo Nordisk